These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prevention of hepatitis B virus reactivation under rituximab therapy.
    Author: Tsutsumi Y, Yamamoto Y, Tanaka J, Asaka M, Imamura M, Masauzi N.
    Journal: Immunotherapy; 2009 Nov; 1(6):1053-61. PubMed ID: 20635919.
    Abstract:
    Rituximab is a useful drug for the treatment of B-cell non-Hodgkin's lymphoma, and its use has been extended to other diseases such as idiopathic thrombocytopenic purpura and chronic rheumatoid arthritis. One serious complication associated with rituximab use is reactivation of hepatitis B virus, and the search for methods to prevent this occurrence has resulted in a rapid accumulation of knowledge in recent years. In this review, we will discuss case studies from our group, as well as other groups, and outline current knowledge on the topic together with issues that remain to be resolved.
    [Abstract] [Full Text] [Related] [New Search]